Mark Epshtein to Disease Models, Animal
This is a "connection" page, showing publications Mark Epshtein has written about Disease Models, Animal.
Connection Strength
0.078
-
King RM, Peker A, Epshtein M, Arends JM, Brochu AB, Raskett CM, Slazas KJ, Puri AS, Arthur AS, Fiorella D, Gounis MJ, Anagnostakou V. Active drug-coated flow diverter in a preclinical model of intracranial stenting. J Neurointerv Surg. 2024 Jun 17; 16(7):731-736.
Score: 0.031
-
Levi M, Epshtein M, Castor T, Gawaz M, Korin N. Glycoprotein VI (GPVI)-functionalized nanoparticles targeting arterial injury sites under physiological flow. Nanomedicine. 2020 10; 29:102274.
Score: 0.024
-
Asaad Y, Epshtein M, Yee A, Korin N. The Flow Dependent Adhesion of von Willebrand Factor (VWF)-A1 Functionalized Nanoparticles in an in Vitro Coronary Stenosis Model. Molecules. 2019 Jul 24; 24(15).
Score: 0.022